On April 6, 2021, Aura Biosciences, Inc. closed the transaction. The company has received $483,829 in its second and final tranche. The transaction included participation from 41 investors.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.22 USD | +1.98% | +0.42% | -18.51% |
Apr. 15 | Raj Parekh to Resign as Member of the Board of Directors of Aura Biosciences, Inc., Effective June 20, 2024 | CI |
Mar. 27 | Aura Biosciences Shares Rise Following Q4 Results | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.51% | 350M | |
+1.51% | 42.59B | |
+8.57% | 40.65B | |
+49.22% | 40.57B | |
-12.36% | 26.77B | |
+8.92% | 24.81B | |
-25.13% | 18.17B | |
+29.17% | 12.05B | |
-3.12% | 11.7B | |
+6.35% | 11.1B |
- Stock Market
- Equities
- AURA Stock
- News Aura Biosciences, Inc.
- Aura Biosciences, Inc. announced that it has received $80.483829 million in funding from a group of investors